trastuzumab,neratinib
roche,knight therapeutics,pierre fabre,puma
['summit', 'neratinib', 'puma', 'pbyi', 'biotec']
$pbyi puma biotechnology presents final results from the biliary tract cohort of the phase 2 summit basket trial of neratinib at the asco 2022 annual meeting #biotech
Free Stock Market News are delayed 15 sec. Full features and live news available here: https://t.co/fWRacb3Vft